5,11- dihydro- 11- ethyl- 5- methyl- 8- (2- (1- oxido- 4- quinolinyl)ethyl)- 6H- dipyrido(3,2- B,2',3'- E)(1,4)diazepin- 6- one

a reverse transcriptase inhibitor; structure in first source

Also Known As:

11-ethyl-5,11-dihydro-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl)-6H-dipyrido(3,2-b,2',3'-e)(1,4)diazepin-6-one; 5,11-dihydro-EMODDO; BILR 355; BILR-355; BILR355

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl)-6H-dipyrido(3,2-B,2',3'-E)(1,4)diazepin-6-one: 1
  - Azepines: 11
    - 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl)-6H-dipyrido(3,2-B,2',3'-E)(1,4)diazepin-6-one: 1

Experts

1.	Hattox, Susan: 1 article (12/2008)
2.	Huang, Fenglei: 1 article (12/2008)
3.	Koenen-Bergmann, Michael: 1 article (12/2008)
4.	Macgregor, Thomas R: 1 article (12/2008)
5.	Ring, Arne: 1 article (12/2008)
6.	Robinson, Patrick: 1 article (12/2008)

Related Diseases

1.	Infections 12/01/2008 - "BILR 355 is a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) under clinical development for the treatment of human immunodeficiency virus infection, particularly in those who harbor virus resistant to the currently available NNRTIs. "

Related Drugs and Biologics

1.	Reverse Transcriptase Inhibitors